Sasano, Hiroyuki http://orcid.org/0000-0003-1420-8745
Shikishima, Keigo
Aoki, Manabu
Sakai, Tsutomu
Tsutsumi, Yuki
Nakano, Tadashi
Funding for this research was provided by:
The Japan Agency for Medical Research and Development (JP17ck0106224)
Article History
Received: 11 April 2019
Revised: 28 June 2019
Accepted: 17 July 2019
First Online: 3 August 2019
Compliance with ethical standards
:
: Hiroyuki Sasano declares that he has no conflict of interest. Keigo Shikishima has received speaker honorariums from Santen Pharmaceutical Co., Ltd., Senju Pharmaceutical Co., Ltd., Johnson and Johnson K.K. and Cosmic Corp. Manabu Aoki declares that he has no conflict of interest. Tsutomu Sakai declares that he has no conflict of interest. Yuki Tsutsumi declares that she has no conflict of interest. Tadashi Nakano has received research grants from Crewt Medical Systems Inc., Kowa Pharmaceutical Co., Ltd., Tomey Corp, Senju Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Merck Sharp and Dohme K.K., Pfizer Inc., Alcon Japan, Ltd., Santen Pharmaceutical Co., Ltd., Nidek Co., Ltd., Johnson and Johnson K.K. and Bayer Yakuhin, Ltd.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Jikei University School of Medicine Ethics Committee (No. 272488133) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.